Steqeyma — Point32Health
Ulcerative Colitis
Preferred products
- Yesintek
Initial criteria
- Documented diagnosis of ulcerative colitis
- Patient age ≥ 18 years
- Prescribed by or in consultation with a gastroenterologist
- Trial and failure of at least two of the listed medications from each of the following therapeutic categories (only one medication is required if only one is available for a listed therapeutic category): Interleukin Antagonists: Omvoh, Skyrizi, Tremfya; Janus Kinase Inhibitors: Rinvoq, Xeljanz; Sphingosine 1-phosphate receptor modulator: Zeposia; Tumor Necrosis Factors: Humira, Simponi OR Contraindication to all of the following medications: Omvoh, Skyrizi, Tremfya, Rinvoq, Xeljanz, Zeposia, Humira and Simponi
- Documented previous failure of or clinical inappropriateness of treatment with Yesintek